Pfizer's Maddaluna on Integrating Wyeth's Manufacturing Organization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pfizer’s Maddaluna on Integrating Wyeth’s Manufacturing Organization



Anthony J. Maddaluna
Senior Vice President, PGM Strategy and Supply Network Transformation
Pfizer, Inc.

Add this Podcast feed to your media player



What is the future of Pfizer’s global manufacturing network following the Wyeth acquisition? In this interview, Tony Maddaluna, senior vice-president of Strategy and Supply Network Transformation at Pfizer Global Manufacturing (PGM), outlines the company’s plans for manufacturing integration.

More Podcasts>>

Related Topic

Big Pharma Tightens Its Global Manufacturing Belt (August 2009)


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search

Click here